16-18794685-T-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_015161.3(ARL6IP1):c.409-2A>G variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,609,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_015161.3 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.409-2A>G | splice_acceptor_variant | ENST00000304414.12 | NP_055976.1 | |||
ARL6IP1 | NM_001313858.1 | c.322-2A>G | splice_acceptor_variant | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.409-2A>G | splice_acceptor_variant | 1 | NM_015161.3 | ENSP00000306788 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249430Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134834
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1457264Hom.: 0 Cov.: 29 AF XY: 0.00000414 AC XY: 3AN XY: 724950
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 61 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 21, 2020 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has not been reported in the literature in individuals with ARL6IP1-related conditions. This variant is present in population databases (rs767874638, ExAC 0.001%). This sequence change affects an acceptor splice site in intron 4 of the ARL6IP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ARL6IP1 are known to be pathogenic (PMID: 24482476, 27848944, 28471035). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at